Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Didanosine; Zidovudine
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb